Foghorn Therapeutics Inc.
NASDAQ:FHTX
4.43 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 55.454 | 80.336 | 345.798 | 101.136 | 92.795 | 14.981 | 40.019 |
| Short Term Investments
| 188.293 | 153.721 | 293.584 | 53.153 | 92.975 | 0 | 0 |
| Cash and Short Term Investments
| 243.747 | 234.057 | 345.798 | 154.289 | 185.77 | 14.981 | 40.019 |
| Net Receivables
| 0 | 0 | 0 | 300 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 5.854 | 6.124 | 5.601 | 5.273 | 9.834 | 1.904 | 0.383 |
| Total Current Assets
| 249.601 | 240.181 | 345.798 | 459.562 | 190.687 | 16.885 | 40.402 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 32.605 | 42.912 | 49.397 | 56.079 | 62.332 | 3.713 | 2.09 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.708 | 1.733 | 1.733 | 1.733 | 0.566 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.776 | 2.823 | 7.98 | 2.4 | 0.842 | 0.011 | 0 |
| Total Non-Current Assets
| 34.381 | 45.735 | 59.085 | 60.212 | 64.907 | 5.457 | 2.656 |
| Total Assets
| 283.982 | 285.916 | 404.883 | 519.774 | 255.594 | 22.342 | 43.058 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 3.785 | 6.26 | 5.414 | 3.819 | 3.68 | 3.439 | 2.014 |
| Short Term Debt
| 9.067 | 8.814 | 11.94 | 13.988 | 7.962 | 5.512 | 0 |
| Tax Payables
| 0 | 0.674 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 45.606 | 34.55 | 336.82 | 28.317 | 2.024 | 3.251 | 0 |
| Other Current Liabilities
| 8.531 | 8.434 | 5.031 | 2.568 | 5.18 | 3.701 | 1.445 |
| Total Current Liabilities
| 66.989 | 58.436 | 336.82 | 48.692 | 18.846 | 12.652 | 3.459 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 28.064 | 36.555 | 45.537 | 51.338 | 78.015 | 97.661 | 7.029 |
| Deferred Revenue Non-Current
| 0 | 268.115 | 304 | 322.73 | 12.546 | 0 | 0.547 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 19.654 | 0 | -0.547 |
| Other Non-Current Liabilities
| 234.457 | 0 | 0.029 | 0.143 | 0 | 0.045 | 71.843 |
| Total Non-Current Liabilities
| 262.521 | 304.67 | 67.951 | 374.211 | 90.561 | 97.706 | 78.872 |
| Total Liabilities
| 329.51 | 363.106 | 404.771 | 422.903 | 109.407 | 110.358 | 82.331 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 255.594 | 86.589 | 71.296 |
| Common Stock
| 0.006 | 0.004 | 0.004 | 0.004 | 0.004 | 0.001 | 0.001 |
| Retained Earnings
| -558.184 | -471.564 | -373.138 | -264.256 | -162.936 | -94.136 | -43.008 |
| Accumulated Other Comprehensive Income/Loss
| 0.135 | -0.826 | -3.986 | -0.01 | -0.007 | -86.59 | -0.616 |
| Other Total Stockholders Equity
| 512.515 | 395.196 | 377.232 | 361.133 | 309.126 | 92.71 | 4.35 |
| Total Shareholders Equity
| -45.528 | -77.19 | 0.112 | 96.871 | 146.187 | -88.016 | -39.273 |
| Total Equity
| -45.528 | -77.19 | 0.112 | 96.871 | 146.187 | -88.016 | -39.273 |
| Total Liabilities & Shareholders Equity
| 283.982 | 285.916 | 404.883 | 519.774 | 255.594 | 22.342 | 43.058 |